Diagnostics development hub to complement biomed research launched

[Press Release by Diagnostics Development Hub]

The Diagnostics Development Hub (DxD) will leverage strategic public-public and public-private partnerships to accelerate market readiness of locally developed diagnostic products.

These include collaborations with the healthcare and academic medical community including SingHealth, National University Health System, National Healthcare Group, as well as academic research organisations like the Singapore Clinical Research Institute. Multinationals such as Johnson & Johnson Innovation and Thermo Fisher Scientific along with SMEs and start-ups such as AITbiotech, Gencurix, HistoIndex, iPtec, InvitroCue, and MiRXES are also among the early supporters of the DxD Hub. 

Click here to read the full release.